Pharmedium Recalls Fentanyl and Bupivacaine Cassettes Due to Glass Particulate
Pharmedium Services, LLC is recalling 220 cassettes of compounded fentanyl and bupivacaine injectable drugs because the active ingredient was contaminated with glass particulate.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the presence of glass particulate in sterile injectable drugs poses a significant risk of injury, meeting the criteria for a Severe rating.
Plain-English summary
Pharmedium Services, LLC is recalling 220 medical cassettes of 2.5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride. The recall is due to the presence of particulate matter, specifically glass particulate, in the active pharmaceutical ingredient (API) used to produce the sterile injectable drugs.
The affected products are distributed nationwide. The recall includes specific lots with Service Codes 2K8210 and 2K8972, with expiration dates ranging from May 6, 2016, to June 27, 2016. The products are compounded by Pharmedium Services, LLC in Memphis, TN.
Healthcare providers and consumers should stop using the affected cassettes and contact Pharmedium Services, LLC for further instructions or a refund.
The recalled product
- Product
- 2.5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Smiths Medical Cassette, flow stop free flow protection, Service Code 2K8972, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-0972-4
- Manufacturer
- Pharmedium Services, LLC
- Category
- Drug — Injectable
- Affected units
- 220
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Service Code 2K8210
- Lot Number 160390175M
- Exp. Date 5/9/2016
- Lot Number 160400226M
- Exp. Date 5/10/2016
- Lot Number 160520170M
- Exp. Date 5/22/2016
- Lot Number 160590066M
- Exp. Date 5/29/2016
- Lot Number 160670046M
- Exp. Date 6/5/2016
- Lot Number 160680006M
- Exp. Date 6/6/2016
- Lot Number 160700027M
- Exp. Date 6/8/2016
- Lot Number 160730069M
- Exp. Date 6/11/2016
- Lot Number 160880217M
- Exp. Date 6/27/2016
- Service Code 2K8972
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 75 recalled by Pharmedium Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 75 products in this recall →Related recalls
Same manufacturer · Pharmedium Services, LLC
See all →- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
Same hazard · glass particulate
See all →- SevereTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighProgesterone Injection Recalled for Glass Particulate Matter in Vials
FDA (Drugs) · 2024-08-07
- HighCyanocobalamin Injection Vials Recalled for Glass Particulate Contamination
FDA (Drugs) · 2024-07-24
- HighEye and Ear Dropper Recalled for Potential Glass Particulate Contamination
FDA (Devices) · 2023-06-21